152 related articles for article (PubMed ID: 21425619)
1. [Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: effects on plasma proteins and coagulation factor VII].
Stanojković Z; Antić A
Vojnosanit Pregl; 2011 Jan; 68(1):51-6. PubMed ID: 21425619
[TBL] [Abstract][Full Text] [Related]
2. [Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates].
Stanojković Z; Antić A; Stojanović M
Vojnosanit Pregl; 2011 Jun; 68(6):489-94. PubMed ID: 21818915
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light].
Antić A; Stanojković Z; Macukanović-Golubović L; Jelić M
Vojnosanit Pregl; 2012 Jan; 69(1):22-6. PubMed ID: 22397292
[TBL] [Abstract][Full Text] [Related]
4. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
Hornsey VS; Drummond O; Morrison A; McMillan L; MacGregor IR; Prowse CV
Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
[TBL] [Abstract][Full Text] [Related]
5. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
Smith J; Rock G
Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
[TBL] [Abstract][Full Text] [Related]
6. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R
Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
[TBL] [Abstract][Full Text] [Related]
7. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
[TBL] [Abstract][Full Text] [Related]
8. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
9. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
Feys HB; Van Aelst B; Devreese K; Devloo R; Coene J; Vandekerckhove P; Compernolle V
Vox Sang; 2014 May; 106(4):307-15. PubMed ID: 24460692
[TBL] [Abstract][Full Text] [Related]
10. Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.
Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
Transfus Apher Sci; 2011 Feb; 44(1):25-31. PubMed ID: 21251884
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of riboflavin photochemical-mediated virus inactivation and changes in protein retention in fresh-frozen plasma treated using a flow-based treatment device.
Zhu L; Pan J; Wei C; Wang H; Xiang R; Zhang J; Wang D
Transfusion; 2015 Jan; 55(1):100-7. PubMed ID: 25070346
[TBL] [Abstract][Full Text] [Related]
12. Towards the understanding of the UV light, riboflavin and additive solution contributions to the in vitro lesions observed in Mirasol®-treated platelets.
Abonnenc M; Crettaz D; Sonego G; Escolar G; Tissot JD; Prudent M
Transfus Clin Biol; 2019 Nov; 26(4):209-216. PubMed ID: 31563447
[TBL] [Abstract][Full Text] [Related]
13. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
Keil SD; Ragan I; Yonemura S; Hartson L; Dart NK; Bowen R
Vox Sang; 2020 Aug; 115(6):495-501. PubMed ID: 32311760
[TBL] [Abstract][Full Text] [Related]
15. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
Tormey CA; Santhanakrishnan M; Smith NH; Liu J; Marschner S; Goodrich RP; Hendrickson JE
Transfusion; 2016 Apr; 56(4):863-72. PubMed ID: 26643781
[TBL] [Abstract][Full Text] [Related]
16. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
Reddy HL; Dayan AD; Cavagnaro J; Gad S; Li J; Goodrich RP
Transfus Med Rev; 2008 Apr; 22(2):133-53. PubMed ID: 18353253
[TBL] [Abstract][Full Text] [Related]
17. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.
Bakkour S; Chafets DM; Wen L; van der Meer PF; Mundt JM; Marschner S; Goodrich RP; Busch MP; Lee TH
Vox Sang; 2014 Nov; 107(4):351-9. PubMed ID: 24976130
[TBL] [Abstract][Full Text] [Related]
18. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.
Keil SD; Bowen R; Marschner S
Transfusion; 2016 Dec; 56(12):2948-2952. PubMed ID: 27805261
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma evaluated with INR-quantification.
Stanojkovic Z; Balint B; Antic A; Todorovic M; Ostojic G; Pavlovic M
Transfus Apher Sci; 2012 Aug; 47(1):33-7. PubMed ID: 22465578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
